Nuances With Defining “Refractory” mCRC in the Third-Line Setting

Panelists discuss how “refractory” metastatic colorectal cancer (mCRC) is defined in the third- vs fourth-line setting, and the treatment goals in the third-line setting, focusing on optimizing patient outcomes and managing progression after prior therapies.

Now Viewing

EP: 1.Nuances With Defining “Refractory” mCRC in the Third-Line Setting

How do you define “refractory” mCRC in the third- vs fourth-line setting, and what are your treatment goals in the third-line setting?